ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase

被引:144
|
作者
Chi, Xun [1 ,2 ]
Britt, Emily C. [1 ,2 ]
Shows, Hannah W. [1 ,2 ]
Hjelmaas, Alexander J. [1 ,2 ]
Shetty, Shwetha K. [1 ,2 ]
Cushing, Emily M. [1 ,2 ]
Li, Wendy [1 ,2 ]
Dou, Alex [1 ,2 ]
Zhang, Ren [4 ]
Davies, Brandon S. J. [1 ,2 ,3 ]
机构
[1] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA
[3] Univ Iowa, Carver Coll Med, Obes Res & Educ Initiat, Iowa City, IA 52242 USA
[4] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 540 East Canfield St, Detroit, MI 48201 USA
来源
MOLECULAR METABOLISM | 2017年 / 6卷 / 10期
基金
美国国家卫生研究院;
关键词
Plasma triglycerides; Lipoprotein metabolism; Lipolysis; Lipase inhibition; TRIGLYCERIDE-RICH LIPOPROTEINS; ENDOTHELIAL-CELL TRANSPORTER; LIPID-METABOLISM; PROTEIN; MICE; IDENTIFICATION; BETATROPHIN; REPORTER; GPIHBP1; HORMONE;
D O I
10.1016/j.molmet.2017.06.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Several members of the angiopoietin-like (ANGPTL) family of proteins, including ANGPTL3 and ANGPTL8, regulate lipoprotein lipase (LPL) activity. Deficiency in either ANGPTL3 or ANGPTL8 reduces plasma triglyceride levels and increases LPL activity, whereas overexpression of either protein does the opposite. Recent studies suggest that ANGPTL8 may functionally interact with ANGPTL3 to alter clearance of plasma triglycerides; however, the nature of this interaction has remained elusive. We tested the hypothesis that ANGPTL8 forms a complex with ANGPTL3 and that this complex is necessary for the inhibition of vascular LPL by ANGPTL3. Methods: We analyzed the interactions of ANGPTL3 and ANGPTL8 with each other and with LPL using co-immunoprecipitation, western blotting, lipase activity assays, and the NanoBiT split-luciferase system. We also used adenovirus injection to overexpress ANGPTL3 in mice that lacked ANGPTL8. Results: We found that ANGPTL3 or ANGPTL8 alone could only inhibit LPL at concentrations that far exceeded physiological levels, especially when LPL was bound to its endothelial cell receptor/transporter GPIHBP1 (glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1). Physical interaction was observed between ANGPTL3 and ANGPTL8 when the proteins were co-expressed, and co-expression with ANGPTL3 greatly enhanced the secretion of ANGPTL8. Importantly, ANGPTL3 ANGPTL8 complexes had a dramatically increased ability to inhibit LPL compared to either protein alone. Adenovirus experiments showed that 2-fold overexpression of ANGPTL3 significantly increased plasma triglycerides only in the presence of ANGPTL8. Protein interaction assays showed that ANGPTL8 greatly increased the ability of ANGPTL3 to bind LPL. Conclusions: Together, these data indicate that ANGPTL8 binds to ANGPTL3 and that this complex is necessary for ANGPTL3 to efficiently bind and inhibit LPL. 2017 The Authors. Published by Elsevier GmbH. (C) 2017 The Authors. Published by Elsevier GmbH.
引用
收藏
页码:1137 / 1149
页数:13
相关论文
共 50 条
  • [31] The study of Angptl3 and Angptl4 in podocyte injury
    Liu, J.
    Shen, Q.
    Dai, R.
    Xu, H.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1833 - 1833
  • [32] Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality
    Silbernagel, Guenther
    Chen, Yan Q.
    Li, Hongxia
    Lemen, Deven
    Wen, Yi
    Zhen, Eugene Y.
    Rief, Martin
    Kleber, Marcus E.
    Delgado, Graciela E.
    Sarzynski, Mark A.
    Qian, Yue-Wei
    Schmidt, Boerge
    Erbel, Raimund
    Trampisch, Ulrike S.
    Moissl, Angela P.
    Rudolf, Henrik
    Schunkert, Heribert
    Stang, Andreas
    Maerz, Winfried
    Trampisch, Hans J.
    Scharnagl, Hubert
    Konrad, Robert J.
    CIRCULATION, 2025, 151 (03) : 218 - 234
  • [34] TRIACYLGLYCEROL-RICH LIPOPROTEINS INFLUENCE THE INACTIVATION OF LIPOPROTEIN LIPASE BY ANGPTL 3 AND ANGPTL 4
    Nilsson, S.
    Larsson, M.
    Lookene, A.
    Heeren, J.
    Olivecrona, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [35] 冠心病患者血清ANGPTL3、ANGPTL8与冠状动脉病变和预后的关系
    王丽媛
    王燕芳
    中国卫生工程学, 2023, 22 (05) : 689 - 691+694
  • [36] ANGPTL3 inhibition for hypercholesterolaemia
    Lim G.B.
    Nature Reviews Cardiology, 2021, 18 (2) : 72 - 72
  • [37] ANGPTL3 as therapeutic target
    Kersten, Sander
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (06) : 335 - 341
  • [38] Expression Of Angptl3 And Angptl4 In Podocyte Injury In Vitro
    Liu, Jiaojiao
    Xu, Hong
    Shen, Qian
    Dai, Rufeng
    Rao, Jia
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1749 - 1749
  • [39] TRIACYLGLYCEROL-RICH LIPOPROTEINS INFLUENCE ON THE INACTIVATION OF LIPOPROTEIN LIPASE BY ANGPTL 3 AND ANGPTL 4
    Nilsson, S.
    Larsson, M.
    Worrsjo, E.
    Lookene, A.
    Suokonina, V.
    Makoveichuk, E.
    Heeren, J.
    Olivecrona, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 30 - 31
  • [40] Short-Term Cooling Increases Plasma ANGPTL3 and ANGPTL8 in Young Healthy Lean Men but Not in Middle-Aged Men with Overweight and Prediabetes
    Janssen, Laura G. M.
    Jauhiainen, Matti
    Olkkonen, Vesa M.
    Haridas, P. A. Nidhina
    Nahon, Kimberly J.
    Rensen, Patrick Cn
    Boon, Mariette R.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)